The FDA warns against compounded variations of unapproved GLP-1 drugs resulting from security and high-quality worries.Vital Takeaway: Retatrutide's side effect profile is similar to tirzepatide and semaglutide. All three share GI signs as the most typical side effects.Because it is effective on all 3, retatrutide tends to produce more robust exces